Who Owns Caribou Biosciences Stock?
NASDAQ: CRBUHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 44.95%
- Held by insiders
- 8.13%
- Institutional holders
- 185
- Institutions 44.9%
- Insiders 8.1%
- Public and other 46.9%
Who owns Caribou Biosciences stock?
Institutional investors own about 44.9% of Caribou Biosciences's shares, spread across 185 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 8.13% of CRBU.
The largest institutional holders are Blackrock Inc. (7.29%), Pfizer Inc (4.38%) and Vanguard Capital Management LLC (3.93%). Together, the top 10 institutions control 30.7% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their CRBU positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of CRBU
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 7.82M | 7.29% | +264.7% |
| Pfizer Inc | 4.69M | 4.38% | 0.0% |
| Vanguard Capital Management LLC | 4.21M | 3.93% | +11.7% |
| Mackenzie Financial Corporation | 3.65M | 3.41% | +287.2% |
| Renaissance Technologies, LLC | 2.77M | 2.59% | +7.1% |
| Kynam Capital Management, LP | 2.50M | 2.34% | 0.0% |
| Geode Capital Management, LLC | 2.37M | 2.22% | +133.3% |
| Acadian Asset Management. LLC | 1.77M | 1.66% | +91.8% |
| State Street Corporation | 1.63M | 1.52% | +285.8% |
| Bank of America Corporation | 1.41M | 1.32% | +8.8% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of CRBU
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.01M | 2.81% |
| iShares Trust-iShares Russell 2000 ETF | 2.26M | 2.11% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.11M | 1.04% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 997.35K | 0.93% |
| iShares Trust-iShares Russell 2000 Value ETF | 871.69K | 0.81% |
| iShares Trust-iShares Biotechnology ETF | 664.13K | 0.62% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 556.73K | 0.52% |
| SCHWAB STRATEGIC TRUST-Schwab U.S. Small-Cap ETF | 425.17K | 0.40% |
| Fidelity Covington Trust-Fidelity Enhanced Small Cap Core ETF | 323.24K | 0.30% |
| iShares Trust-iShares Micro-Cap ETF | 319.26K | 0.30% |
Frequently asked questions
Who is the largest shareholder of Caribou Biosciences?
Blackrock Inc. is the largest institutional shareholder of CRBU, owning 7.29% of shares outstanding (7.82M shares) as of its latest 13F filing.
What percentage of Caribou Biosciences is owned by institutions?
Institutions own about 44.9% of CRBU shares and 48.9% of the public float.
How much of Caribou Biosciences do insiders own?
Insiders, such as officers and directors, own about 8.13% of CRBU shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.